Kojin Bio (177A) Earnings: Revenue Down 20.1% YoY to 974 Million Yen with Operating Loss of 54 Million Yen

Kojin Bio (177A) has released its financial results, reporting net sales of 974 million yen, representing a 20.1% decrease compared to the same period of the previous year. On the profit front, the company posted an operating loss of 54 million yen, an ordinary loss of 36 million yen, and a net loss attributable to owners of the parent of 41 million yen. Earnings per share (EPS) stood at -8.2 yen, with comprehensive income recorded at -12 million yen. Meanwhile, the company maintains a solid financial foundation with an equity ratio of 66.9%. Retained earnings stand at 3.3 billion yen against interest-bearing debt of 1.84 billion yen, highlighting the importance of future earnings recovery and balance sheet management.